CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 50 of 86 entries

View as:

The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women

Phase: N/A Priority: Normal

NCT ID: NCT00141557 Org: User:

Start: 07/31/04 End: 03/31/08 Due: 03/31/09

Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT00510484 Org: User:

Start: 11/30/07 End: 03/31/08 Due: 03/31/09

Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT00134251 Org: User:

Start: 10/31/05 End: - Due: -

A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT00349284 Org: User:

Start: 01/31/05 End: - Due: -

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Phase: N/A Priority: Normal

NCT ID: NCT00347425 Org: User:

Start: 12/31/06 End: 02/29/08 Due: 02/28/09

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

Phase: N/A Priority: Normal

NCT ID: NCT00642499 Org: User:

Start: 08/31/03 End: 04/30/05 Due: 04/30/06

The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women

Phase: N/A Priority: Normal

NCT ID: NCT00141544 Org: User:

Start: 07/31/04 End: 03/31/08 Due: 03/31/09

Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00349128 Org: User:

Start: 01/31/04 End: - Due: -

Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure

Phase: N/A Priority: Normal

NCT ID: NCT00998933 Org: User:

Start: 10/31/09 End: 10/31/09 Due: 10/31/10

Efficacy and Safety of Moxonidine in Indian Patients

Phase: N/A Priority: Normal

NCT ID: NCT00160277 Org: User:

Start: 07/31/05 End: - Due: -

Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache

Phase: N/A Priority: Normal

NCT ID: NCT00123201 Org: User:

Start: 09/30/05 End: 03/31/07 Due: 03/31/08

Bifeprunox in the Treatment of Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00193713 Org: User:

Start: 05/31/05 End: 11/30/06 Due: 11/30/07

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal

NCT ID: NCT00160147 Org: User:

Start: 12/31/05 End: 01/31/08 Due: 01/31/09

Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People

Phase: N/A Priority: Normal

NCT ID: NCT00543647 Org: User:

Start: 08/31/02 End: 03/31/03 Due: 03/31/04

First in Man Study With SLV341

Phase: N/A Priority: Normal

NCT ID: NCT00887445 Org: User:

Start: 07/31/08 End: 05/31/09 Due: 05/31/10

Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT00885989 Org: User:

Start: 05/31/09 End: 12/31/09 Due: 12/31/10

Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00141492 Org: User:

Start: 10/31/04 End: 06/30/07 Due: 06/30/08

Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy

Phase: N/A Priority: Normal

NCT ID: NCT00160238 Org: User:

Start: 01/31/03 End: - Due: -

An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients

Phase: N/A Priority: Normal

NCT ID: NCT00332917 Org: User:

Start: 02/28/07 End: 07/31/08 Due: 07/31/09

Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years

Phase: N/A Priority: Normal

NCT ID: NCT00599443 Org: User:

Start: 10/31/07 End: 05/31/08 Due: 05/31/09

Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT00139906 Org: User:

Start: 08/31/05 End: 10/31/06 Due: 10/31/07

SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations

Phase: N/A Priority: Normal

NCT ID: NCT00406588 Org: User:

Start: 03/31/07 End: 05/31/08 Due: 05/31/09

Effects of Fenofibrate on Gene Expression in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT01109758 Org: User:

Start: 03/31/08 End: 08/31/08 Due: 08/31/09

Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women

Phase: N/A Priority: Normal

NCT ID: NCT00160264 Org: User:

Start: 01/31/03 End: - Due: -

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT00160160 Org: User:

Start: 10/31/04 End: - Due: -

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women	NCT00141557	Solvay Pharmaceuticals	user2@example.com	None	2004-07-31	2008-03-31	2009-03-31	-	-	2025-07-14
Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis	NCT00510484	Solvay Pharmaceuticals	user2@example.com	None	2007-11-30	2008-03-31	2009-03-31	-	-	2025-07-14
Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease	NCT00134251	Solvay Pharmaceuticals	user2@example.com	None	2005-10-31	-	-	-	-	2025-07-14
A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome	NCT00349284	Solvay Pharmaceuticals	user2@example.com	None	2005-01-31	-	-	-	-	2025-07-14
Switch Study of Existing Atypical Antipsychotics to Bifeprunox	NCT00347425	Solvay Pharmaceuticals	user2@example.com	None	2006-12-31	2008-02-29	2009-02-28	-	-	2025-07-14
Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting	NCT00642499	Solvay Pharmaceuticals	user2@example.com	None	2003-08-31	2005-04-30	2006-04-30	-	-	2025-07-14
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women	NCT00141544	Solvay Pharmaceuticals	user2@example.com	None	2004-07-31	2008-03-31	2009-03-31	-	-	2025-07-14
Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes	NCT00349128	Solvay Pharmaceuticals	user2@example.com	None	2004-01-31	-	-	-	-	2025-07-14
Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure	NCT00998933	Solvay Pharmaceuticals	user2@example.com	None	2009-10-31	2009-10-31	2010-10-31	-	-	2025-07-14
Efficacy and Safety of Moxonidine in Indian Patients	NCT00160277	Solvay Pharmaceuticals	user2@example.com	None	2005-07-31	-	-	-	-	2025-07-14
Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache	NCT00123201	Solvay Pharmaceuticals	user2@example.com	None	2005-09-30	2007-03-31	2008-03-31	-	-	2025-07-14
Bifeprunox in the Treatment of Schizophrenia	NCT00193713	Solvay Pharmaceuticals	user2@example.com	None	2005-05-31	2006-11-30	2007-11-30	-	-	2025-07-14
Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type	NCT00160147	Solvay Pharmaceuticals	user2@example.com	None	2005-12-31	2008-01-31	2009-01-31	-	-	2025-07-14
Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People	NCT00543647	Solvay Pharmaceuticals	user2@example.com	None	2002-08-31	2003-03-31	2004-03-31	-	-	2025-07-14
First in Man Study With SLV341	NCT00887445	Solvay Pharmaceuticals	user2@example.com	None	2008-07-31	2009-05-31	2010-05-31	-	-	2025-07-14
Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers	NCT00885989	Solvay Pharmaceuticals	user2@example.com	None	2009-05-31	2009-12-31	2010-12-31	-	-	2025-07-14
Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes	NCT00141492	Solvay Pharmaceuticals	user2@example.com	None	2004-10-31	2007-06-30	2008-06-30	-	-	2025-07-14
Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy	NCT00160238	Solvay Pharmaceuticals	user2@example.com	None	2003-01-31	-	-	-	-	2025-07-14
An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients	NCT00332917	Solvay Pharmaceuticals	user2@example.com	None	2007-02-28	2008-07-31	2009-07-31	-	-	2025-07-14
Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years	NCT00599443	Solvay Pharmaceuticals	user2@example.com	None	2007-10-31	2008-05-31	2009-05-31	-	-	2025-07-14
Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia	NCT00139906	Solvay Pharmaceuticals	user2@example.com	None	2005-08-31	2006-10-31	2007-10-31	-	-	2025-07-14
SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations	NCT00406588	Solvay Pharmaceuticals	user2@example.com	None	2007-03-31	2008-05-31	2009-05-31	-	-	2025-07-14
Effects of Fenofibrate on Gene Expression in Healthy Volunteers	NCT01109758	Solvay Pharmaceuticals	user2@example.com	None	2008-03-31	2008-08-31	2009-08-31	-	-	2025-07-14
Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women	NCT00160264	Solvay Pharmaceuticals	user2@example.com	None	2003-01-31	-	-	-	-	2025-07-14
Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes	NCT00160160	Solvay Pharmaceuticals	user2@example.com	None	2004-10-31	-	-	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance